NeoGenomics' Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk MelanomaBusiness Wire • 12/11/24
NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual MeetingBusiness Wire • 12/09/24
ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical ResearchBusiness Wire • 12/05/24
NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized TreatmentBusiness Wire • 11/19/24
NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare ConferenceBusiness Wire • 11/08/24
NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 11/06/24
NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 11/05/24
Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to TradeZacks Investment Research • 11/04/24
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor TestBusiness Wire • 10/22/24
NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 10/08/24
NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid LeukemiaBusiness Wire • 10/08/24
NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 LitigationBusiness Wire • 09/23/24
NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized TreatmentBusiness Wire • 09/11/24
NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceBusiness Wire • 08/29/24
Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q2 EarningsZacks Investment Research • 07/29/24
Fort Myers' Mayor to Proclaim June as NeoGenomics' Commitment to Cancer MonthBusiness Wire • 06/13/24